STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 9, 2026

Period of Report

March 5, 2026

Accession Number

0001780660-26-000007